Rosen Quoted on Generic Drug Applications

07 March 2008 FDA Week News

Foley Partner David Rosen is quoted in the March 7, 2008 issue of FDA Week on how the FDA is dealing with the backlog of generic drug applications. Rosen, a former generics drug office official, comments that it takes a considerable amount of time to find qualified and efficient people to proficiently review generic drug applications.

Related Services

Insights

ERISA/Cybersecurity Considerations in the COVID Age
21 October 2020
Privacy, Cybersecurity & Technology Law Perspectives
A Review of Recent Whistleblower Developments
21 October 2020
Legal News: Whistleblower Developments
U.S. EPA Formalizes Reversal of “Once In/Always In” Emission Permitting Policy
21 October 2020
Legal News: Environmental
Georgia Finalizes New Telemedicine Practice Rules
21 October 2020
Health Care Law Today
Discover Telehealth Conference
18 November 2020
Webinar
ACI’s Proficiency Series on Rx Drug Pricing and Rebate Fundamentals
17-19 November 2020
Webinar
2020 NDI Reimagined
11-13 November 2020
Webinar
Foley’s Annual Government Contracts Update
10 November 2020